Follow
Dana Angelini
Dana Angelini
Verified email at ccf.org
Title
Cited by
Cited by
Year
NCCN guidelines insights: cancer-associated venous thromboembolic disease, version 2.2018
MB Streiff, B Holmstrom, D Angelini, A Ashrani, PL Bockenstedt, ...
Journal of the National Comprehensive Cancer Network 16 (11), 1289-1303, 2018
2322018
Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology
MB Streiff, B Holmstrom, D Angelini, A Ashrani, A Elshoury, J Fanikos, ...
Journal of the National Comprehensive Cancer Network 19 (10), 1181-1201, 2021
1772021
Risk of hematologic malignancies after radioiodine treatment of well-differentiated thyroid cancer
RJ Molenaar, S Sidana, T Radivoyevitch, AS Advani, AT Gerds, ...
Journal of clinical oncology 36 (18), 1831, 2018
1372018
Direct oral anticoagulants for the treatment of acute venous thromboembolism associated with cancer: a systematic review and meta-analysis
M Giustozzi, G Agnelli, J del Toro-Cervera, FA Klok, RP Rosovsky, ...
Thrombosis and haemostasis 120 (07), 1128-1136, 2020
1322020
Bleeding incidence and risk factors among cancer patients treated with anticoagulation
DE Angelini, T Radivoyevitch, KR McCrae, AA Khorana
American journal of hematology 94 (7), 780-785, 2019
1202019
Aging among persons with hemophilia: contemporary concerns
D Angelini, BA Konkle, SL Sood
Seminars in Hematology 53 (1), 35-39, 2016
482016
Risk assessment scores for cancer-associated venous thromboembolic disease
D Angelini, AA Khorana
Seminars in thrombosis and hemostasis 43 (05), 469-478, 2017
352017
Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study
F Covut, R Ahmed, S Chawla, F Ricaurte, CJ Samaras, F Anwer, ...
British Journal of Haematology 193 (6), 1213-1219, 2021
342021
Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine
RJ Molenaar, C Pleyer, T Radivoyevitch, S Sidana, A Godley, AS Advani, ...
Leukemia 32 (4), 952-959, 2018
342018
COVID‐19 and venous thromboembolism: A narrative review
DE Angelini, S Kaatz, RP Rosovsky, RL Zon, S Pillai, WE Robertson, ...
Research and Practice in Thrombosis and Haemostasis 6 (2), e12666, 2022
232022
Clinical outcomes of isolated distal deep vein thrombosis versus proximal venous thromboembolism in cancer patients: The Cleveland Clinic experience
SK Poudel, DY Park, X Jia, M Wilks, V Pinkava, M O’Brien, B Tripp, ...
Journal of Thrombosis and Haemostasis 18 (3), 651-659, 2020
232020
Managing older patients with hemophilia
D Angelini, SL Sood
Hematology 2014, the American Society of Hematology Education Program Book …, 2015
222015
Polyphosphate expression by cancer cell extracellular vesicles mediates binding of factor XII and contact activation
YJ Shim, V Chatterjee, S Swaidani, RK Alluri, S Kundu, A Merkulova, ...
Blood advances 5 (22), 4741-4751, 2021
202021
Use of GMI‐1271, an E‐selectin antagonist, in healthy subjects and in 2 patients with calf vein thrombosis
S Devata, DE Angelini, S Blackburn, A Hawley, DD Myers, JK Schaefer, ...
Research and Practice in Thrombosis and Haemostasis 4 (2), 193-204, 2020
182020
First in human phase 1 single dose escalation studies of the E-selectin antagonist GMI-1271 show a favorable safety, pharmacokinetic, and biomarker profile
S Devata, SL Sood, MV Hemmer, H Flanner, W Kramer, C Nietubicz, ...
Blood 126 (23), 1004, 2015
162015
Implementation of an electronic medical record tool for early detection of deep vein thrombosis in the ambulatory oncology setting
G Kunapareddy, B Switzer, P Jain, M Conces, YW Chen, B Patel, S Patel, ...
Research and Practice in Thrombosis and Haemostasis 3 (2), 226-233, 2019
142019
New diagnosis of G6PD deficiency presenting as severe rhabdomyolysis
AS Eziokwu, D Angelini
Cureus 10 (3), 2018
142018
Updated guidelines for immune thrombocytopenic purpura: Expanded management options
S DeSouza, D Angelini
Cleveland Clinic Journal of Medicine 88 (12), 664-668, 2021
132021
Thromboembolism in patients with metastatic renal cell carcinoma treated with immunotherapy
IY Sheng, S Gupta, CA Reddy, D Angelini, P Funchain, TA Sussman, ...
Targeted Oncology 16 (6), 813-821, 2021
122021
NCCN clinical practice guidelines in oncology: cancer-associated venous thromboembolic disease
MB Streiff, B Holmstrom, D Angelini, A Ashrani, T Buckner, J Fanikos, ...
Plymouth Meeting, PA: National Comprehensive Cancer Network, 2019
122019
The system can't perform the operation now. Try again later.
Articles 1–20